Efficacy of ultrasound-guided hydrocele aspiration to prevent surgical intervention

Kumasi Centre for Collaborative Research (KCCR)0 个研究点目标入组 60 人开始时间: 2022年3月8日最近更新: 2022年3月21日

适应症

试验速览

暂无简介。

•1. Ultrasound determined hydrocele stage 2 – 4 as described by Debrah et al., 2007, however, participants with stage 4 should not have fluid volume more than 500 ml as determined by ultrasound
•2. Male patients aged 18 - 55 years
•3. Resident in the endemic area for 2 years or more
•4. Able and willing to give informed consent to participate in the study

•1. Age <18 or >55 years
•2. No hydrocele or stage 1 hydrocele(s) only
•3. Hydrocele of unknown cause
•4. Stage 4 hydrocele with a fluid volume >500 ml determined by ultrasound and other stages that require hydrocelectomy
•5. Thickened, fibrosed or calcified tunica vaginalis assessed by ultrasound
•6. Haemorrhagic fluid or necrotic testis(es) assessed by ultrasound
•7. Resident in the area for <2 years
•8. Hernia assessed by ultrasound
•9. History of bleeding tendencies
•10. History of haemophilia
•11. Chronic liver disease
•12. Coagulopathies
•13. History of severe allergic reaction or anaphylaxis due to anaesthetic drugs
•14. Participation in drug trials concurrent with this study
•15. Any other condition or severe comorbidities (except for features of the filarial disease) that, in the opinion of the study clinician, would risk the safety or rights of a participant or would render the subject unable to comply with the protocol.
•16. Intake of blood thinners (warfarin, heparin, aspirin)
•17. Intake of diuretics
•18. Unable to give informed consent

发起方

Kumasi Centre for Collaborative Research (KCCR)